{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:49:16Z","timestamp":1775058556340,"version":"3.50.1"},"reference-count":34,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/zuhl5679","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:15:14Z","timestamp":1753942514000},"page":"5081-5089","source":"Crossref","is-referenced-by-count":1,"title":["Clinical effectiveness of ethinylestradiol-cyproterone acetate and raloxifene combination therapy in polycystic ovary syndrome-associated infertility"],"prefix":"10.62347","volume":"17","author":[{"given":"Pengyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J and Teede HJ. Polycystic ovary syndrome. Lancet Diabetes Endocrinol 2022; 10: 668-680.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","unstructured":"Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F and Kumar M. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med 2023; 12: 1454.","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X and He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 2023; 16: 9.","journal-title":"J Ovarian Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"SF","year":"2019","unstructured":"Witchel SF, Oberfield SE and Pena AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 2019; 3: 1545-1573.","journal-title":"J Endocr Soc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3390\/diagnostics14222578","article-title":"Deciphering the role of androgen in the dermatologic manifestations of polycystic ovary syndrome patients: a state-of-the-art review","volume":"14","author":"Taieb","year":"2024","unstructured":"Taieb A and Feryel A. Deciphering the role of androgen in the dermatologic manifestations of polycystic ovary syndrome patients: a state-of-the-art review. Diagnostics (Basel) 2024; 14: 2578.","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/humrep\/dead241","article-title":"Global, regional, and national burden of infertility attributable to PCOS, 1990-2019","volume":"39","author":"Liu","year":"2024","unstructured":"Liu X, Zhang J and Wang S. Global, regional, and national burden of infertility attributable to PCOS, 1990-2019. Hum Reprod 2024; 39: 108-118.","journal-title":"Hum Reprod"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","article-title":"Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing","volume":"23","author":"Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A and Abdollahi M. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci 2022; 23: 583.","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Guo Z, Afza R, Moneeb Khan M, Khan SU, Khan MW, Ali Z, Batool S and Din FU. Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses. Heliyon 2023; 9: e20107.","DOI":"10.1016\/j.heliyon.2023.e20107"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Condi FLF, Fuchs LFP, Carvalho KC and Baracat EC. Treatment with raloxifene induces the expression of kisspeptin, insulin, and androgen receptors in bones of castrated adult female rats. Rev Bras Ortop (Sao Paulo) 2024; 59: e228-e234.","DOI":"10.1055\/s-0044-1779319"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/cbdd.13152","article-title":"Enhanced cytotoxicity and apoptosis by raloxifene in combination with estrogen and methotrexate in human endometrial stromal cells","volume":"91","author":"Nikolic","year":"2018","unstructured":"Nikolic I, Andjelkovic M, Zaric M, Zelen I, Milosavljevic Z, Canovic P and Mitrovic M. Enhanced cytotoxicity and apoptosis by raloxifene in combination with estrogen and methotrexate in human endometrial stromal cells. Chem Biol Drug Des 2018; 91: 885-892.","journal-title":"Chem Biol Drug Des"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.3390\/ijms25169037","article-title":"The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: a molecular and cellular review of the literature","volume":"25","author":"KJ","year":"2024","unstructured":"Chang KJ, Chen JH and Chen KH. The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: a molecular and cellular review of the literature. Int J Mol Sci 2024; 25: 9037.","journal-title":"Int J Mol Sci"},{"key":"ref11","unstructured":"Lu K, Li N, Zhang M, Lin J and Chen J. Effects of letrozole combined with ethinylestradiol and cyproterone acetate tablets on serum sex hormones and lipid metabolism in patients with polycystic ovary syndrome. Am J Transl Res 2023; 15: 1271-1280."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"106801","DOI":"10.1016\/j.prostaglandins.2023.106801","article-title":"Analysis on the therapeutic effect of Cangfu Daotan Decoction combined with drospirenone and ethinylestradiol tablets (II) on patients with polycystic ovary syndrome","volume":"170","author":"Fu","year":"2024","unstructured":"Fu Y, Xie P, Yang Q, Chen P and Yu J. Analysis on the therapeutic effect of Cangfu Daotan Decoction combined with drospirenone and ethinylestradiol tablets (II) on patients with polycystic ovary syndrome. Prostaglandins Other Lipid Mediat 2024; 170: 106801.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K and Piltonen TT. Polycystic ovary syndrome. Nat Rev Dis Primers 2024; 10: 27.","journal-title":"Nat Rev Dis Primers"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.21037\/apm-21-3638","article-title":"Clinical efficacy and safety of the Jinfeng pill in the adjuvant treatment of infertility in patients with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trial","volume":"11","author":"Xu","year":"2022","unstructured":"Xu Y, Han YM, Xu W, Shi C, Chen YE and Li N. Clinical efficacy and safety of the Jinfeng pill in the adjuvant treatment of infertility in patients with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trial. Ann Palliat Med 2022; 11: 352-362.","journal-title":"Ann Palliat Med"},{"key":"ref15","unstructured":"Oliver A and Overton C. Detecting ovarian disorders in primary care. Practitioner 2014; 258: 15-19, 2."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1237260","DOI":"10.3389\/fendo.2023.1237260","article-title":"Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial","volume":"14","author":"Chang","year":"2023","unstructured":"Chang H, Shi B, Ge H, Liu C, Wang L, Ma C, Liu L, Zhang W, Zhang D, Wang Y, Wang CC and Wu X. Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial. Front Endocrinol (Lausanne) 2023; 14: 1237260.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1070264","DOI":"10.3389\/fendo.2023.1070264","article-title":"Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis","volume":"14","author":"Peng","year":"2023","unstructured":"Peng Q, Chen X, Liang X, Ouyang J, Wang Q, Ren S, Xie H, Wang C, Sun Y, Wu X, Liu H, Hei C, Sun M, Chang Q, Liu X, Li G and He R. Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis. Front Endocrinol (Lausanne) 2023; 14: 1070264.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3712166","DOI":"10.1155\/2022\/3712166","article-title":"The effects of letrozole and metformin combined with targeted nursing care on ovarian function, LH, and FSH in infertile patients with polycystic ovary syndrome","volume":"2022","author":"Jiang","year":"2022","unstructured":"Jiang S, Tang T, Sheng Y, Li R and Xu H. The effects of letrozole and metformin combined with targeted nursing care on ovarian function, LH, and FSH in infertile patients with polycystic ovary syndrome. J Healthc Eng 2022; 2022: 3712166.","journal-title":"J Healthc Eng"},{"key":"ref19","unstructured":"Yang J, Lin QP, You XM, Zhang JX, Liu Y, Huang J, Dun JJ, Huang S, Xu JB and Ji F. Effect of combined treatment with acupuncture, moxibustion and medication on endometrial receptivity and expression of serum HOXA10 in polycystic ovary syndrome of kidney deficiency and blood stagnation. Zhongguo Zhen Jiu 2020; 40: 1154-1158."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1148556","DOI":"10.3389\/fendo.2023.1148556","article-title":"Effects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Yang","year":"2023","unstructured":"Yang M, Shen X, Lu D, Peng J, Zhou S, Xu L and Zhang J. Effects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2023; 14: 1148556.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12958-023-01075-9","article-title":"The effects of first-line pharmacological treatments for reproductive outcomes in infertile women with PCOS: a systematic review and network meta-analysis","volume":"21","author":"Peng","year":"2023","unstructured":"Peng G, Yan Z, Liu Y, Li J, Ma J, Tong N and Wang Y. The effects of first-line pharmacological treatments for reproductive outcomes in infertile women with PCOS: a systematic review and network meta-analysis. Reprod Biol Endocrinol 2023; 21: 24.","journal-title":"Reprod Biol Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Attia GM, Almouteri MM and Alnakhli FT. Role of metformin in polycystic ovary syndrome (PCOS)-related infertility. Cureus 2023; 15: e44493.","DOI":"10.7759\/cureus.44493"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40618-020-01349-8","article-title":"Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial","volume":"44","author":"Amiri","year":"2021","unstructured":"Amiri M, Rahmati M, Hedayati M, Nahidi F and Ramezani Tehrani F. Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial. J Endocrinol Invest 2021; 44: 567-580.","journal-title":"J Endocrinol Invest"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/09513590.2017.1395841","article-title":"Treatment strategies for women with polycystic ovary syndrome","volume":"34","author":"Jin","year":"2018","unstructured":"Jin P and Xie Y. Treatment strategies for women with polycystic ovary syndrome. Gynecol Endocrinol 2018; 34: 272-277.","journal-title":"Gynecol Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.fertnstert.2011.06.067","article-title":"Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome","volume":"96","author":"de Paula Guedes Neto","year":"2011","unstructured":"de Paula Guedes Neto E, Savaris RF, von Eye Corleta H, de Moraes GS, do Amaral Cristovam R and Lessey BA. Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome. Fertil Steril 2011; 96: 769-773.","journal-title":"Fertil Steril"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13625187.2017.1317735","article-title":"Use of cyproterone acetate\/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects","volume":"22","author":"Ruan","year":"2017","unstructured":"Ruan X, Kubba A, Aguilar A and Mueck AO. Use of cyproterone acetate\/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects. Eur J Contracept Reprod Health Care 2017; 22: 183-190.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref27","unstructured":"Singhal R, Tewari S, Sharma R, Singhal S, Tanwar N and Sangwan A. Effect of cyproterone acetate\/ethinyl estradiol combination on periodontal status and high-sensitivity C-reactive protein levels in women with polycystic ovary syndrome: a cross-sectional study. Quintessence Int 2024; 55: 274-285."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Mhao NS, Al-Hilli AS, Hadi NR, Jamil DA and Al-Aubaidy HA. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome. Diabetes Metab Syndr 2016; 10 Suppl 1: S95-98.","DOI":"10.1016\/j.dsx.2015.10.001"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/humrep\/dei312","article-title":"Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance","volume":"21","author":"Lemay","year":"2006","unstructured":"Lemay A, Dodin S, Turcot L, Dechene F and Forest JC. Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance. Hum Reprod 2006; 21: 121-128.","journal-title":"Hum Reprod"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"106539","DOI":"10.1016\/j.jsbmb.2024.106539","article-title":"Metabolism of endogenous and exogenous estrogens in women","volume":"242","author":"Stanczyk","year":"2024","unstructured":"Stanczyk FZ. Metabolism of endogenous and exogenous estrogens in women. J Steroid Biochem Mol Biol 2024; 242: 106539.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"907874","DOI":"10.3389\/fendo.2022.907874","article-title":"An endometrial receptivity scoring system basing on the endometrial thickness, volume, echo, peristalsis, and blood flow evaluated by ultrasonography","volume":"13","author":"Zhang","year":"2022","unstructured":"Zhang CH, Chen C, Wang JR, Wang Y, Wen SX, Cao YP and Qian WP. An endometrial receptivity scoring system basing on the endometrial thickness, volume, echo, peristalsis, and blood flow evaluated by ultrasonography. Front Endocrinol (Lausanne) 2022; 13: 907874.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"104381","DOI":"10.1016\/j.rbmo.2024.104381","article-title":"Pharmacological and non-pharmacological interventions for improving endometrial receptivity in infertile patients with polycystic ovary syndrome: a comprehensive review of the available evidence","volume":"49","author":"Palomba","year":"2024","unstructured":"Palomba S, Costanzi F, Caserta D and Vitagliano A. Pharmacological and non-pharmacological interventions for improving endometrial receptivity in infertile patients with polycystic ovary syndrome: a comprehensive review of the available evidence. Reprod Biomed Online 2024; 49: 104381.","journal-title":"Reprod Biomed Online"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/2042018812437355","article-title":"The effects of old, new and emerging medicines on metabolic aberrations in PCOS","volume":"3","author":"Bargiota","year":"2012","unstructured":"Bargiota A and Diamanti-Kandarakis E. The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab 2012; 3: 27-47.","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0166232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:51:57Z","timestamp":1766022717000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0166232.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zuhl5679","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}